BREAKING: Spanish Researchers Announce They Have Cured Pancreatic Cancer In Mice

Researchers in Spain have reported encouraging results from a new experimental treatment for pancreatic cancer, according to a study published January 28, 2026, in Nature Cancer.

The study, conducted by scientists at the Spanish National Cancer Research Centre (CNIO), found that a triple-therapy approach fully eliminated pancreatic tumors in mice. Of the 18 mice treated, 16 remained disease-free for more than 200 days, with researchers observing no significant side effects during the study period.

How the Therapy Works

In video footage released alongside the findings, Dr. Mariano Barbacid, a leading cancer researcher at CNIO, explained that the therapy targets three essential biological pathways that pancreatic tumors rely on to grow and survive.

By attacking all three pathways at once, the researchers aimed to prevent the cancer from adapting or developing resistance — a common problem with single-drug treatments. According to Barbacid, this multi-target approach was key to the therapy’s effectiveness in preclinical trials.

Importantly, the research team reported that the treatment did not produce the clinical side effects often seen in experimental cancer therapies at this stage.

Why the Findings Matter

Pancreatic cancer is one of the most difficult cancers to treat and has seen limited improvements in survival rates over the past several decades. Tumor resistance and late-stage diagnosis remain major challenges, making new therapeutic strategies particularly significant.

While the results are limited to animal models, experts note that complete tumor elimination combined with long-term remission is uncommon in pancreatic cancer research, even at the preclinical level.

What Comes Next

The researchers emphasized that the therapy has not yet been tested in humans, and further studies will be required before clinical trials can begin. Many treatments that show promise in mice do not ultimately prove effective or safe in people.

Still, the findings represent an important step forward and provide a strong foundation for additional research.

For now, the study adds cautious optimism to a field in need of new approaches, while underscoring the long and careful process required to translate laboratory results into human treatments.